🧪 Beta — BiohacksAI is under active development. Data and features may change.
B
BiohacksAI
Evidence-Based Biohacking
BetaPatent Pending

Mk 0249

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Mk 0249, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

pitolisant
2 shared targets
irdabisant
2 shared targets
Nicergoline
2 shared targets
dilazep
2 shared targets
risperidone
2 shared targets
Dequalinium
2 shared targets
Fluoxetine
2 shared targets
pentamidine
2 shared targets
Aripiprazole
2 shared targets
Metergoline
2 shared targets
Loading evidence profile...

This evidence profile for Mk 0249 is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.